Pseudomonas aeruginosa Biofilms
- PMID: 33212950
- PMCID: PMC7698413
- DOI: 10.3390/ijms21228671
Pseudomonas aeruginosa Biofilms
Abstract
Pseudomonas aeruginosa is an opportunistic human pathogen causing devastating acute and chronic infections in individuals with compromised immune systems. Its highly notorious persistence in clinical settings is attributed to its ability to form antibiotic-resistant biofilms. Biofilm is an architecture built mostly by autogenic extracellular polymeric substances which function as a scaffold to encase the bacteria together on surfaces, and to protect them from environmental stresses, impedes phagocytosis and thereby conferring the capacity for colonization and long-term persistence. Here we review the current knowledge on P. aeruginosa biofilms, its development stages, and molecular mechanisms of invasion and persistence conferred by biofilms. Explosive cell lysis within bacterial biofilm to produce essential communal materials, and interspecies biofilms of P. aeruginosa and commensal Streptococcus which impedes P. aeruginosa virulence and possibly improves disease conditions will also be discussed. Recent research on diagnostics of P. aeruginosa infections will be investigated. Finally, therapeutic strategies for the treatment of P. aeruginosa biofilms along with their advantages and limitations will be compiled.
Keywords: Pseudomonas aeruginosa; biofilms; quorum sensing.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures


Similar articles
-
Pseudomonas aeruginosa biofilm: treatment strategies to combat infection.Arch Microbiol. 2025 May 10;207(6):141. doi: 10.1007/s00203-025-04346-8. Arch Microbiol. 2025. PMID: 40348909 Review.
-
Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.PLoS One. 2017 Apr 28;12(4):e0176883. doi: 10.1371/journal.pone.0176883. eCollection 2017. PLoS One. 2017. PMID: 28453568 Free PMC article.
-
Does Pseudomonas aeruginosa use intercellular signalling to build biofilm communities?Cell Microbiol. 2006 Dec;8(12):1841-9. doi: 10.1111/j.1462-5822.2006.00817.x. Epub 2006 Oct 4. Cell Microbiol. 2006. PMID: 17026480 Review.
-
Targeting quorum sensing in Pseudomonas aeruginosa biofilms: current and emerging inhibitors.Future Microbiol. 2013 Jul;8(7):901-21. doi: 10.2217/fmb.13.57. Future Microbiol. 2013. PMID: 23841636 Review.
-
The role of bacterial biofilms in chronic infections.APMIS Suppl. 2013 May;(136):1-51. doi: 10.1111/apm.12099. APMIS Suppl. 2013. PMID: 23635385
Cited by
-
A Novel Bacteriophage Infecting Multi-Drug- and Extended-Drug-Resistant Pseudomonas aeruginosa Strains.Antibiotics (Basel). 2024 Jun 3;13(6):523. doi: 10.3390/antibiotics13060523. Antibiotics (Basel). 2024. PMID: 38927189 Free PMC article.
-
Antibacterial and cytocompatible silver coating for titanium Boston Keratoprosthesis.Front Bioeng Biotechnol. 2024 Sep 19;12:1421706. doi: 10.3389/fbioe.2024.1421706. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 39364264 Free PMC article.
-
Novel Antimicrobial Approaches to Combat Bacterial Biofilms Associated with Urinary Tract Infections.Antibiotics (Basel). 2024 Feb 4;13(2):154. doi: 10.3390/antibiotics13020154. Antibiotics (Basel). 2024. PMID: 38391540 Free PMC article. Review.
-
Role of R5 Pyocin in the Predominance of High-Risk Pseudomonas aeruginosa Isolates.bioRxiv [Preprint]. 2024 Oct 7:2024.10.07.616987. doi: 10.1101/2024.10.07.616987. bioRxiv. 2024. Update in: Microbiol Res. 2025 Oct;299:128244. doi: 10.1016/j.micres.2025.128244. PMID: 39416193 Free PMC article. Updated. Preprint.
-
Two cinnamoyl hydroxamates as potential quorum sensing inhibitors against Pseudomonas aeruginosa.Front Cell Infect Microbiol. 2024 Aug 6;14:1424038. doi: 10.3389/fcimb.2024.1424038. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 39165918 Free PMC article.
References
-
- Wu W., Jin Y., Bai F., Jin S. Chapter 41—Pseudomonas Aeruginosa. In: Tang Y.-W., Sussman M., Liu D., Poxton I., Schwartzman J., editors. Molecular Medical Microbiology. 2nd ed. Academic Press; Cambridge, MA, USA: 2015. pp. 753–767. - DOI
-
- Gomila A., Carratalà J., Badia J.M., Camprubí D., Piriz M., Shaw E., Diaz-Brito V., Espejo E., Nicolás C., Brugués M., et al. Preoperative oral antibiotic prophylaxis reduces Pseudomonas aeruginosa surgical site infections after elective colorectal surgery: A multicenter prospective cohort study. BMC Infect. Dis. 2018;18:507. doi: 10.1186/s12879-018-3413-1. - DOI - PMC - PubMed
-
- World Health Organization . Prioritization of Pathogens to Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis. World Health Organization; Geneva, Switzerland: 2017.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources